Brain atrophy in Alzheimer's Disease and aging
2016-01-01 Pini, L.; Pievani, M.; Bocchetta, M.; Altomare, D.; Bosco, P.; Cavedo, E.; Galluzzi, S.; Marizzoni, M.; Frisoni, G. B.
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease
2018-01-01 Drzezga, A.; Altomare, D.; Festari, C.; Arbizu, J.; Orini, S.; Herholz, K.; Nestor, P.; Agosta, F.; Bouwman, F.; Nobili, F.; Walker, Z.; Frisoni, G. B.; Boccardi, M.
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
2018-01-01 Nobili, F.; Festari, C.; Altomare, D.; Agosta, F.; Orini, S.; Van Laere, K.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Walker, Z.; Boccardi, M.
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
2018-01-01 Agosta, F.; Altomare, D.; Festari, C.; Orini, S.; Gandolfo, F.; Boccardi, M.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Pagani, M.
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
2018-01-01 Walker, Z.; Gandolfo, F.; Orini, S.; Garibotto, V.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Boccardi, M.; Altomare, D.; Festari, C.; Nobili, F.
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
2018-01-01 Nestor, P. J.; Altomare, D.; Festari, C.; Drzezga, A.; Rivolta, J.; Walker, Z.; Bouwman, F.; Orini, S.; Law, I.; Agosta, F.; Arbizu, J.; Boccardi, M.; Nobili, F.; Frisoni, G. B.
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
2018-01-01 Bouwman, F.; Orini, S.; Gandolfo, F.; Altomare, D.; Festari, C.; Agosta, F.; Arbizu, J.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Morbelli, S.; Boccardi, M.
Clinical utility of FDG-PET for the clinical diagnosis in MCI
2018-01-01 Arbizu, J.; Festari, C.; Altomare, D.; Walker, Z.; Bouwman, F.; Rivolta, J.; Orini, S.; Barthel, H.; Agosta, F.; Drzezga, A.; Nestor, P.; Boccardi, M.; Frisoni, G. B.; Nobili, F.
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
2018-01-01 Nobili, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Agosta, F.; Nestor, P.; Walker, Z.; Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S.
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
2018-01-01 Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S.; Nobili, F.; Frisoni, G. B.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Walker, Z.
Comment: Is a Large-Scale Screening for Alzheimer's Disease Possible? Yes, in a Few Years
2019-01-01 Ribaldi, F.; Altomare, D.; Frisoni, G. B.
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies
2020-01-01 Frisoni, G. B.; Molinuevo, J. L.; Altomare, D.; Carrera, E.; Barkhof, F.; Berkhof, J.; Delrieu, J.; Dubois, B.; Kivipelto, M.; Nordberg, A.; Schott, J. M.; van der Flier, W. M.; Vellas, B.; Jessen, F.; Scheltens, P.; Ritchie, C.
Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6
2021-01-01 Brioschi Guevara, A.; Bieler, M.; Altomare, D.; Berthier, M.; Csajka, C.; Dautricourt, S.; Demonet, J. -F.; Dodich, A.; Frisoni, G. B.; Miniussi, C.; Molinuevo, J. L.; Ribaldi, F.; Scheltens, P.; Chetelat, G.
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6
2021-01-01 Ranson, J. M.; Rittman, T.; Hayat, S.; Brayne, C.; Jessen, F.; Blennow, K.; van Duijn, C.; Barkhof, F.; Tang, E.; Mummery, C. J.; Stephan, B. C. M.; Altomare, D.; Frisoni, G. B.; Ribaldi, F.; Molinuevo, J. L.; Scheltens, P.; Llewellyn, D. J.; Abramowicz, M.; Berthier, M.; Bieler, M.; Brioschi, A.; Carrera, E.; Chetelat, G.; Csajka, C.; Demonet, J. -F.; Dodich, A.; Dubois, B.; Garibotto, V.; Georges, J.; Hurst, S.; Kivipelto, M.; Mcwhirter, L.; Milne, R.; Minguillon, C.; Miniussi, C.; Nilsson, P. M.; Ritchie, C.; Solomon, A.; van der Flier, W.; Vellas, B.; Visser, L.
Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6
2021-01-01 Milne, R.; Altomare, D.; Ribaldi, F.; Molinuevo, J. L.; Frisoni, G. B.; Brayne, C.
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6
2021-01-01 Altomare, D.; Molinuevo, J. L.; Ritchie, C.; Ribaldi, F.; Carrera, E.; Dubois, B.; Jessen, F.; Mcwhirter, L.; Scheltens, P.; van der Flier, W. M.; Vellas, B.; Demonet, J. -F.; Frisoni, G. B.; Abramowicz, M.; Altomare, D.; Barkhof, F.; Berthier, M.; Bieler, M.; Blennow, K.; Brayne, C.; Brioschi, A.; Chetelat, G.; Csajka, C.; Demonet, J. -F.; Dodich, A.; Garibotto, V.; Georges, J.; Hurst, S.; Kivipelto, M.; Llewellyn, D.; Milne, R.; Minguillon, C.; Miniussi, C.; Nilsson, P. M.; Ranson, J.; Solomon, A.; van Der Flier, W.; van Duijn, C.; Visser, L.
Dementia risk communication. A user manual for Brain Health Services—part 3 of 6
2021-01-01 Visser, L. N. C.; Minguillon, C.; Sanchez-Benavides, G.; Abramowicz, M.; Altomare, D.; Fauria, K.; Frisoni, G. B.; Georges, J.; Ribaldi, F.; Scheltens, P.; van der Schaar, J.; Zwan, M.; van der Flier, W. M.; Molinuevo, J. L.
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives
2021-01-01 Cotta Ramusino, M.; Perini, G.; Altomare, D.; Barbarino, P.; Weidner, W.; Salvini Porro, G.; Barkhof, F.; Rabinovici, G. D.; van der Flier, W. M.; Frisoni, G. B.; Garibotto, V.; Teipel, S.; Boccardi, M.
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6
2021-01-01 Solomon, A.; Stephen, R.; Altomare, D.; Carrera, E.; Frisoni, G. B.; Kulmala, J.; Molinuevo, J. L.; Nilsson, P.; Ngandu, T.; Ribaldi, F.; Vellas, B.; Scheltens, P.; Kivipelto, M.; Abramowicz, M.; Barkhof, F.; Berthier, M.; Bieler, M.; Blennow, K.; Brayne, C.; Brioschi, A.; Chetelat, G.; Csajka, C.; Demonet, J. -F.; Dodich, A.; Dubois, B.; Garibotto, V.; Georges, J.; Hurst, S.; Jessen, F.; Llewellyn, D.; Mcwhirter, L.; Milne, R.; Minguillon, C.; Miniussi, C.; Nilsson, P. M.; Ranson, J.; Ritchie, C.; Solomon, A.; van Duijn, C.; van der Flier, W.; Visser, L.
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
2022-01-01 Frisoni, G. B.; Altomare, D.; Thal, D. R.; Ribaldi, F.; van der Kant, R.; Ossenkoppele, R.; Blennow, K.; Cummings, J.; van Duijn, C.; Nilsson, P. M.; Dietrich, P. -Y.; Scheltens, P.; Dubois, B.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Brain atrophy in Alzheimer's Disease and aging | 1-gen-2016 | Pini, L.; Pievani, M.; Bocchetta, M.; Altomare, D.; Bosco, P.; Cavedo, E.; Galluzzi, S.; Marizzoni, M.; Frisoni, G. B. | |
| Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease | 1-gen-2018 | Drzezga, A.; Altomare, D.; Festari, C.; Arbizu, J.; Orini, S.; Herholz, K.; Nestor, P.; Agosta, F.; Bouwman, F.; Nobili, F.; Walker, Z.; Frisoni, G. B.; Boccardi, M. | |
| Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders | 1-gen-2018 | Nobili, F.; Festari, C.; Altomare, D.; Agosta, F.; Orini, S.; Van Laere, K.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Walker, Z.; Boccardi, M. | |
| Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease | 1-gen-2018 | Agosta, F.; Altomare, D.; Festari, C.; Orini, S.; Gandolfo, F.; Boccardi, M.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Pagani, M. | |
| Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia | 1-gen-2018 | Walker, Z.; Gandolfo, F.; Orini, S.; Garibotto, V.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Boccardi, M.; Altomare, D.; Festari, C.; Nobili, F. | |
| Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia | 1-gen-2018 | Nestor, P. J.; Altomare, D.; Festari, C.; Drzezga, A.; Rivolta, J.; Walker, Z.; Bouwman, F.; Orini, S.; Law, I.; Agosta, F.; Arbizu, J.; Boccardi, M.; Nobili, F.; Frisoni, G. B. | |
| Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia | 1-gen-2018 | Bouwman, F.; Orini, S.; Gandolfo, F.; Altomare, D.; Festari, C.; Agosta, F.; Arbizu, J.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Morbelli, S.; Boccardi, M. | |
| Clinical utility of FDG-PET for the clinical diagnosis in MCI | 1-gen-2018 | Arbizu, J.; Festari, C.; Altomare, D.; Walker, Z.; Bouwman, F.; Rivolta, J.; Orini, S.; Barthel, H.; Agosta, F.; Drzezga, A.; Nestor, P.; Boccardi, M.; Frisoni, G. B.; Nobili, F. | |
| European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus | 1-gen-2018 | Nobili, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Agosta, F.; Nestor, P.; Walker, Z.; Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S. | |
| Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia | 1-gen-2018 | Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S.; Nobili, F.; Frisoni, G. B.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Walker, Z. | |
| Comment: Is a Large-Scale Screening for Alzheimer's Disease Possible? Yes, in a Few Years | 1-gen-2019 | Ribaldi, F.; Altomare, D.; Frisoni, G. B. | |
| Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies | 1-gen-2020 | Frisoni, G. B.; Molinuevo, J. L.; Altomare, D.; Carrera, E.; Barkhof, F.; Berkhof, J.; Delrieu, J.; Dubois, B.; Kivipelto, M.; Nordberg, A.; Schott, J. M.; van der Flier, W. M.; Vellas, B.; Jessen, F.; Scheltens, P.; Ritchie, C. | |
| Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6 | 1-gen-2021 | Brioschi Guevara, A.; Bieler, M.; Altomare, D.; Berthier, M.; Csajka, C.; Dautricourt, S.; Demonet, J. -F.; Dodich, A.; Frisoni, G. B.; Miniussi, C.; Molinuevo, J. L.; Ribaldi, F.; Scheltens, P.; Chetelat, G. | |
| Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 | 1-gen-2021 | Ranson, J. M.; Rittman, T.; Hayat, S.; Brayne, C.; Jessen, F.; Blennow, K.; van Duijn, C.; Barkhof, F.; Tang, E.; Mummery, C. J.; Stephan, B. C. M.; Altomare, D.; Frisoni, G. B.; Ribaldi, F.; Molinuevo, J. L.; Scheltens, P.; Llewellyn, D. J.; Abramowicz, M.; Berthier, M.; Bieler, M.; Brioschi, A.; Carrera, E.; Chetelat, G.; Csajka, C.; Demonet, J. -F.; Dodich, A.; Dubois, B.; Garibotto, V.; Georges, J.; Hurst, S.; Kivipelto, M.; Mcwhirter, L.; Milne, R.; Minguillon, C.; Miniussi, C.; Nilsson, P. M.; Ritchie, C.; Solomon, A.; van der Flier, W.; Vellas, B.; Visser, L. | |
| Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6 | 1-gen-2021 | Milne, R.; Altomare, D.; Ribaldi, F.; Molinuevo, J. L.; Frisoni, G. B.; Brayne, C. | |
| Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 | 1-gen-2021 | Altomare, D.; Molinuevo, J. L.; Ritchie, C.; Ribaldi, F.; Carrera, E.; Dubois, B.; Jessen, F.; Mcwhirter, L.; Scheltens, P.; van der Flier, W. M.; Vellas, B.; Demonet, J. -F.; Frisoni, G. B.; Abramowicz, M.; Altomare, D.; Barkhof, F.; Berthier, M.; Bieler, M.; Blennow, K.; Brayne, C.; Brioschi, A.; Chetelat, G.; Csajka, C.; Demonet, J. -F.; Dodich, A.; Garibotto, V.; Georges, J.; Hurst, S.; Kivipelto, M.; Llewellyn, D.; Milne, R.; Minguillon, C.; Miniussi, C.; Nilsson, P. M.; Ranson, J.; Solomon, A.; van Der Flier, W.; van Duijn, C.; Visser, L. | |
| Dementia risk communication. A user manual for Brain Health Services—part 3 of 6 | 1-gen-2021 | Visser, L. N. C.; Minguillon, C.; Sanchez-Benavides, G.; Abramowicz, M.; Altomare, D.; Fauria, K.; Frisoni, G. B.; Georges, J.; Ribaldi, F.; Scheltens, P.; van der Schaar, J.; Zwan, M.; van der Flier, W. M.; Molinuevo, J. L. | |
| Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives | 1-gen-2021 | Cotta Ramusino, M.; Perini, G.; Altomare, D.; Barbarino, P.; Weidner, W.; Salvini Porro, G.; Barkhof, F.; Rabinovici, G. D.; van der Flier, W. M.; Frisoni, G. B.; Garibotto, V.; Teipel, S.; Boccardi, M. | |
| Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 | 1-gen-2021 | Solomon, A.; Stephen, R.; Altomare, D.; Carrera, E.; Frisoni, G. B.; Kulmala, J.; Molinuevo, J. L.; Nilsson, P.; Ngandu, T.; Ribaldi, F.; Vellas, B.; Scheltens, P.; Kivipelto, M.; Abramowicz, M.; Barkhof, F.; Berthier, M.; Bieler, M.; Blennow, K.; Brayne, C.; Brioschi, A.; Chetelat, G.; Csajka, C.; Demonet, J. -F.; Dodich, A.; Dubois, B.; Garibotto, V.; Georges, J.; Hurst, S.; Jessen, F.; Llewellyn, D.; Mcwhirter, L.; Milne, R.; Minguillon, C.; Miniussi, C.; Nilsson, P. M.; Ranson, J.; Ritchie, C.; Solomon, A.; van Duijn, C.; van der Flier, W.; Visser, L. | |
| The probabilistic model of Alzheimer disease: the amyloid hypothesis revised | 1-gen-2022 | Frisoni, G. B.; Altomare, D.; Thal, D. R.; Ribaldi, F.; van der Kant, R.; Ossenkoppele, R.; Blennow, K.; Cummings, J.; van Duijn, C.; Nilsson, P. M.; Dietrich, P. -Y.; Scheltens, P.; Dubois, B. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista214
Data di pubblicazione
- 2020 - 202459
- 2010 - 2019102
- 2000 - 200934
- 1990 - 199916
- 1984 - 19893
Editore
- Casa editrice Dottor Eugenio Joven1
Rivista
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...9
- JASSS8
- ALZHEIMER'S RESEARCH & THERAPY6
- L'ANALISI LINGUISTICA E LETTERARIA5
- RASSEGNA ITALIANA DI LINGUISTICA ...5
- EUROPEAN UROLOGY4
- RIVISTA DI STORIA DELLA MEDICINA4
- VERITAS ET JUS4
- ELECTRONIC JOURNAL OF APPLIED STA...3
- EUROPEAN JOURNAL OF PROBATION3
Keyword
- Humans12
- Alzheimer’s disease9
- Dementia8
- FDG-PET7
- Aging6
- Prevention6
- Brain Health Services3
- Cardiology and Cardiovascular Med...3
- Cognitive enhancement3
- Oncology3
Lingua
- eng123
- ita74
Accesso al fulltext
- no fulltext147
- open31
- reserved25
- restricted11